Treatment of Trichomoniasis in Patients Consuming Alcohol

First-line Treatment and Alcohol Interaction Concerns

Metronidazole is the standard first-line treatment for trichomoniasis, with cure rates of approximately 90-95%, and is available as a 2g single dose or 500mg twice daily for 7 days, according to the Centers for Disease Control and Prevention 1, 2
Metronidazole can cause a disulfiram-like reaction when combined with alcohol, which may include nausea, vomiting, flushing, headache, and abdominal cramps, as reported by the Centers for Disease Control and Prevention 3, 4
For patients actively consuming alcohol and unwilling to undergo detoxification, this interaction poses a significant treatment challenge, as noted by the Centers for Disease Control and Prevention 2

The Centers for Disease Control and Prevention recommends ensuring treatment of all sexual partners to prevent reinfection 1, 2
The Centers for Disease Control and Prevention advises patients to abstain from sexual activity until both they and their partners complete treatment and are asymptomatic 2
Follow-up is unnecessary for patients who become asymptomatic after treatment, according to the Centers for Disease Control and Prevention 1
If symptoms persist after treatment, the Centers for Disease Control and Prevention suggests considering reinfection or resistant infection 5

For pregnant patients, the Centers for Disease Control and Prevention recommends metronidazole 2g single dose after the first trimester 6, 7
For patients with HIV infection, the Centers for Disease Control and Prevention states that the same treatment regimens apply as for HIV-negative individuals 5
For patients with true metronidazole allergy, the Centers for Disease Control and Prevention notes that desensitization may be required as effective alternatives are limited 1, 5

The Centers for Disease Control and Prevention warns that topical metronidazole gel is NOT effective for trichomoniasis (efficacy <50%) and should not be used 1, 5
Failure to treat sexual partners is a common cause of recurrent infection, as reported by the Centers for Disease Control and Prevention 2, 4
Resistant T. vaginalis strains are increasingly reported; consultation with specialists may be needed for persistent cases, according to the Centers for Disease Control and Prevention 5
If treatment fails repeatedly, the Centers for Disease Control and Prevention suggests considering susceptibility testing of T. vaginalis to metronidazole/tinidazole 1